Stereotaxis (STXS): Price and Financial Metrics


Stereotaxis (STXS): $9.11

-0.28 (-2.98%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

STXS POWR Grades


  • Quality is the dimension where STXS ranks best; there it ranks ahead of 86.44% of US stocks.
  • STXS's strongest trending metric is Quality; it's been moving up over the last 31 weeks.
  • STXS ranks lowest in Momentum; there it ranks in the 15th percentile.

STXS Stock Summary

  • The ratio of debt to operating expenses for Stereotaxis Inc is higher than it is for about just 15.71% of US stocks.
  • With a price/sales ratio of 23.67, Stereotaxis Inc has a higher such ratio than 91.3% of stocks in our set.
  • The volatility of Stereotaxis Inc's share price is greater than that of 85.34% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Stereotaxis Inc are DSPG, CVLT, PHR, BLDP, and SWAV.
  • STXS's SEC filings can be seen here. And to visit Stereotaxis Inc's official web site, go to www.stereotaxis.com.

STXS Valuation Summary

  • STXS's price/earnings ratio is -92.4; this is 371.76% lower than that of the median Healthcare stock.
  • STXS's price/earnings ratio has moved down 86.4 over the prior 206 months.
  • Over the past 206 months, STXS's EV/EBIT ratio has gone down 102.

Below are key valuation metrics over time for STXS.

Stock Date P/S P/B P/E EV/EBIT
STXS 2016-04-22 0.9 -2.0 -4.8 -11.9
STXS 2015-06-05 0.9 -2.3 -8.0 -54.6
STXS 2013-07-05 0.2 -0.5 -1.2 -34.0
STXS 2006-08-02 23.0 4.0 -5.3 -4.5
STXS 2006-02-02 17.2 11.2 -9.0 -9.0
STXS 2005-06-27 10.4 3.8 -7.1 -6.4

STXS Growth Metrics

  • Its 2 year revenue growth rate is now at -11.21%.
  • The 5 year cash and equivalents growth rate now stands at 674.49%.
  • Its 4 year net income to common stockholders growth rate is now at 9.73%.
Over the past 30 months, STXS's revenue has gone down $137,827.

The table below shows STXS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 29.49635 -1.651173 -7.565574
2020-12-31 26.63003 -3.511772 -8.01588
2020-09-30 26.6981 -5.734686 -7.937102
2020-06-30 26.19626 -5.657559 -6.337928
2020-03-31 27.64892 -5.005504 -5.859608
2019-12-31 28.90255 -4.61668 -6.020684

STXS Stock Price Chart Interactive Chart >

Price chart for STXS

STXS Price/Volume Stats

Current price $9.11 52-week high $10.30
Prev. close $9.39 52-week low $3.03
Day low $9.04 Volume 301,814
Day high $9.44 Avg. volume 403,733
50-day MA $8.89 Dividend yield N/A
200-day MA $6.42 Market Cap 675.18M

Stereotaxis (STXS) Company Bio


Stereotaxis Inc. designs, manufactures, and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The Company markets Stereotaxis System in the United States and Europe.


STXS Latest News Stream


Event/Time News Detail
Loading, please wait...

STXS Latest Social Stream


Loading social stream, please wait...

View Full STXS Social Stream

Latest STXS News From Around the Web

Below are the latest news stories about Stereotaxis Inc that investors may wish to consider to help them evaluate STXS as an investment opportunity.

Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.

ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Myriam J. Curet, M.D., to its Board of Directors. Dr. Curet currently serves as Executive Vice President and Chief Medical Officer for Intuitive Surgical, the global leader and pioneer of robotic surgery. Dr. Curet joined Intuitive Surgical in 2005 and has since led the development of clinical evid

Yahoo | July 26, 2021

Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments. What:Stereotaxis second quarter 2021 fi

Yahoo | July 20, 2021

Here's Why "Trend" Investors Would Love Betting on Stereotaxis Inc. (STXS)

If you are looking for stocks that are well positioned to maintain their recent uptrend, Stereotaxis Inc. (STXS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Yahoo | June 29, 2021

Stereotaxis (NYSEAMERICAN:STXS) Issues Earnings Results

Stereotaxis (NYSEAMERICAN:STXS) released its earnings results on Monday. The company reported ($0.02) earnings per share for the quarter, beating the Zacks consensus estimate of ($0.03) by $0.01, MarketWatch Earnings reports. Stereotaxis had a negative net margin of 24.54% and a negative return on equity of 22.78%. Stereotaxis stock opened at $7.00 on Wednesday. The firms []

Dakota Financial News | May 12, 2021

Stereotaxis (STXS) Q1 2021 Earnings Call Transcript

Thank you for joining us for the Stereotaxis first-quarter 2021 earnings conference call. During the first quarter, we shipped a Genesis and Model S system to a hospital establishing a new robotic electrophysiology program in Europe, as well as Niobe system to a hospital establishing a new robotic electrophysiology program in China.

Yahoo | May 10, 2021

Read More 'STXS' Stories Here

STXS Price Returns

1-mo -5.50%
3-mo 26.53%
6-mo 89.40%
1-year 137.86%
3-year 1,015.60%
5-year 652.89%
YTD 78.98%
2020 -3.78%
2019 389.36%
2018 35.13%
2017 23.10%
2016 -12.18%

Continue Researching STXS

Want to see what other sources are saying about Stereotaxis Inc's financials and stock price? Try the links below:

Stereotaxis Inc (STXS) Stock Price | Nasdaq
Stereotaxis Inc (STXS) Stock Quote, History and News - Yahoo Finance
Stereotaxis Inc (STXS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.842 seconds.